AT323155B - Verfahren zur herstellung von neuen tetrahydrocarbazolderivaten und ihren salzen - Google Patents

Verfahren zur herstellung von neuen tetrahydrocarbazolderivaten und ihren salzen

Info

Publication number
AT323155B
AT323155B AT449173A AT449173A AT323155B AT 323155 B AT323155 B AT 323155B AT 449173 A AT449173 A AT 449173A AT 449173 A AT449173 A AT 449173A AT 323155 B AT323155 B AT 323155B
Authority
AT
Austria
Prior art keywords
salt
preparation
tetrahydrocarbazole derivatives
new
new tetrahydrocarbazole
Prior art date
Application number
AT449173A
Other languages
German (de)
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of AT323155B publication Critical patent/AT323155B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT449173A 1972-05-25 1973-05-23 Verfahren zur herstellung von neuen tetrahydrocarbazolderivaten und ihren salzen AT323155B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
AT323155B true AT323155B (de) 1975-06-25

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT449173A AT323155B (de) 1972-05-25 1973-05-23 Verfahren zur herstellung von neuen tetrahydrocarbazolderivaten und ihren salzen

Country Status (12)

Country Link
JP (1) JPS4941367A (enExample)
AT (1) AT323155B (enExample)
AU (1) AU5607873A (enExample)
BE (1) BE800066A (enExample)
CA (1) CA1005062A (enExample)
CH (1) CH582144A5 (enExample)
CS (1) CS179416B2 (enExample)
DD (1) DD106170A5 (enExample)
DE (1) DE2226703A1 (enExample)
FR (1) FR2185414B1 (enExample)
GB (1) GB1436893A (enExample)
NL (1) NL7307313A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033797A1 (en) * 1979-08-06 1981-08-19 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles, their preparation, pharmaceutical compositions containing same and their preparation, intermediates therefor and their preparation

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
WO2004026116A2 (en) 2002-09-19 2004-04-01 The Regents Of The University Of California Use of etodoclac to treat hyperplasia
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
WO2005026112A2 (en) * 2003-09-12 2005-03-24 Elixir Pharmaceuticals, Inc. Methods of treating a disorder
TW200526668A (en) * 2003-10-02 2005-08-16 Salmedix Inc Substituted indole derivatives
CN104311472B9 (zh) * 2008-07-23 2020-03-17 艾尼纳制药公司 经取代的1,2,3,4-四氢环戊并[b]吲哚-3-基乙酸衍生物
PL2342205T4 (pl) 2008-08-27 2016-12-30 Podstawione tricykliczne pochodne kwasowe jako antagoniści receptora S1P1 użyteczni w leczeniu zaburzeń autoimmunologicznych i zapalnych
EP2528894A1 (en) 2010-01-27 2012-12-05 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN105503882B (zh) 2010-03-03 2019-07-05 艾尼纳制药公司 制备s1p1受体调节剂及其晶体形式的方法
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ, インコーポレイテッド S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
KR20190113955A (ko) 2017-02-16 2019-10-08 아레나 파마슈티칼스, 인크. 장-외 증상을 갖는 염증성 장질환의 치료를 위한 화합물 및 방법
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法
EP3847158B1 (en) 2018-09-06 2026-06-24 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (enExample) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033797A1 (en) * 1979-08-06 1981-08-19 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles, their preparation, pharmaceutical compositions containing same and their preparation, intermediates therefor and their preparation

Also Published As

Publication number Publication date
CA1005062A (en) 1977-02-08
CH582144A5 (enExample) 1976-11-30
JPS4941367A (enExample) 1974-04-18
FR2185414A1 (enExample) 1974-01-04
DD106170A5 (enExample) 1974-06-05
AU5607873A (en) 1974-11-28
GB1436893A (en) 1976-05-26
DE2226703A1 (de) 1973-12-13
CS179416B2 (en) 1977-10-31
NL7307313A (enExample) 1973-11-27
BE800066A (fr) 1973-11-26
FR2185414B1 (enExample) 1976-08-13

Similar Documents

Publication Publication Date Title
AT325607B (de) Verfahren zur herstellung von neuen carbacolderivaten und ihren salzen
AT325034B (de) Verfahren zur herstellung von neuen benzofuranderivaten und ihren salzen
AT322543B (de) Verfahren zur herstellung von neuen indolderivaten und ihren salzen
AT324325B (de) Verfahren zur herstellung von neuen 1-äthyl-imidazolen und ihren salzen
AT323738B (de) Verfahren zur herstellung von neuen anilinobenzothiazolderivaten und ihren salzen
AT326669B (de) Verfahren zur herstellung von neuen pyrazin-4-oxid-derivaten und salzen davon
AT332425B (de) Verfahren zur herstellung von neuen 6-aminouracilen und ihren salzen
AT330767B (de) Verfahren zur herstellung von neuen imidazolinderivaten und ihren salzen
AT328455B (de) Verfahren zur herstellung von neuen nitroimidazolylpyrimidinderivaten und ihren salzen
AT323740B (de) Verfahren zur herstellung von neuen chinolinderivaten und ihren salzen
ATA780273A (de) Verfahren zur herstellung von neuen pyrrolidinderivaten und ihren salzen
AT325052B (de) Verfahren zur herstellung von neuen 6-azabenzo-1,5-diazepinen und ihren salzen
AT332409B (de) Verfahren zur herstellung von neuen diazepinderivaten und ihren 5-oxiden und salzen
AT332874B (de) Verfahren zur herstellung von neuen naphthyridinderivaten und ihren salzen
AT324324B (de) Verfahren zur herstellung von neuen 2-imidazolidinon-derivaten und ihren salzen
AT329553B (de) Verfahren zur herstellung von neuen imidazolinderivaten und ihren salzen
AT329567B (de) Verfahren zur herstellung von neuen homopyrimidazolderivaten und ihren salzen
AT334906B (de) Verfahren zur herstellung von neuen phthalazinderivaten und ihren salzen
ATA627175A (de) Verfahren zur herstellung von neuen aminoimidazoloisochinolinderivaten und ihren salzen
ATA316077A (de) Verfahren zur herstellung von neuen aminoimidazoloisochinolinderivaten und ihren salzen
ATA541574A (de) Verfahren zur herstellung von neuen anilinobenzothiazolderivaten und ihren salzen
AT320636B (de) Verfahren zur Herstellung von neuen Phenylimidazolidinonderivaten und ihren Salzen
ATA97774A (de) Verfahren zur herstellung von neuen phenylimidazolidinonderivaten und ihren salzen
ATA97874A (de) Verfahren zur herstellung von neuen phenylimidazolidinonderivaten und ihren salzen
ATA627375A (de) Verfahren zur herstellung von neuen aminopyrazoloisochinolinderivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee